FEDERATION EQUESTRE INTERNATIONALE FEI
PRESS NEWS 16/05 10 APRIL 2005 
FEI
GENERAL ASSEMBLY The FEI Task Force on Anti Doping and Medication Policy Presents
its Report to the Forum The FEI Task Force on Anti
Doping and Medication Policy was established in November 2004 and was asked
to look into the existent FEI system of medication control which, while robust,
required changes to better reflect equestrian sport of the 21st century. The Task
Force also dealt with the ensuing judicial procedure. It came up with a series
of modifications that would improve the system and make it more transparent
and equitable. It is important to note that the FEI has a more conservative and
stricter approach to prohibited substances than the one laid down by the World
Anti-Doping Agency (WADA).
The terms of reference for the Task Force were
the clear differentiation between doping and medication; the definition of the
list of illegal substances and tolerance levels; laboratory analysis and legal
procedures; sanctions; internal and external communication policy; crisis management
and handling of high profile cases. Recommendations:
The
basis of Task Force's recommendations is the protection of the integrity and cleanliness
of the sport, whilst recognising that horses are competitive athletes who deserve
the greatest care and whose welfare is paramount. Legitimate treatment must be
applied when necessary and it should not be withheld for fear of breaking medication
rules. This concept is fundamental and can only be assured if all concerned have
a clear understanding of what treatment can be used, when it can be used and what
the consequences are for abusing the treatment. Consequently, a new FEI Medication
Code was adopted. It is based on the distinction between medication control, aimed
at preventing medication violation that may affect performance or mask an underlying
health problem whilst providing appropriate treatment to safeguard the health
and welfare of the competition horse, and doping control the goal of which is
to prevent any attempt to alter the horse's performance by the administration
or application of prohibited substances in or on the horse's body. Medicine
Box and Withdrawal Times:
Riders and treating veterinarians
have called for the publication of a list of accepted equine medications and their
withdrawal times before competition (Medicine Box). This is a complicated area
since the rate in which a substance deteriorates in a horse's body varies considerably
from one horse to another. However, it is recommended that all withdrawal times
for medications in the "Medicine Box" be established within a year.
Recommended
Levels of Detection:
There is also a regular argument that the
levels found are so low that they could have no effect on the horse's performance.
It is important to bear in mind that concentrations are not necessarily an accurate
way to measure the effect on the horse in question. Concentrations depend on three
main factors: when the substance was given; the route in which it was administered
and the amount administered. These factors all affect the concentration found
and do not give an indication whether or not the substance was effective at that
particular time. However, recommended levels of detection (RLODs), have been
established through extensive research. They can be used to effectively indicate
if the substance has any effect at the level found. To establish RLODs and withdrawal
time recommendations, a Medication Advisory Group, consisting of professionals
in veterinary medicine and representatives of the sport, should be created. To
enable the system to work effectively, it is essential that a list of acceptable
drugs, with guidance as to withdrawal times and RLODs will be supplied. Grading
of Substances:
Substances should be re-classified from the current
1 to 5 grading to the following: Doping: agents, cocktails of substances
that affect the performance of a horse; masking agents; substances with
no generally accepted medical use in competition horses and which are usually
products prescribed for human use only. Agents used to hypersensitive or sensitise
the limbs or body parts. Medication Class A: agents which could influence
performance by relieving pain, sedating, stimulating or producing/modifying other
physiological or behavioural effects. Medication Class B: substances
that either have limited performance enhancing potential or to which horses may
have been exposed, including certain dietary contaminants. Testing
Procedure and Laboratories:
The testing procedure was carefully
examined and it was decided that deadlines will be shortened. There will one central
laboratory and three reference laboratories. The central lab will be in Europe
as this is where the majority of high level events are and the remaining three
will be in the USA, Australia and Hong Kong. All laboratories servicing the
FEI must be able to accommodate the RLODs established by the FEI. Judicial
Process:
The current judicial system does not allow for an investigating
body and aprosecuting system. An organisational procedure was therefore agreed
upon in order to speed up the process and strengthen the FEI Legal Department.
The FEI Judicial Committee will be composed of seven - and no longer three - independent
members with legal backgrounds. The chairman and the members of the Judicial Committee
should not have any interactions with FEI Personnel that may influence their
decision making. This guarantee's the independence of the judicial process. Sanctions: Doping:
up to two years suspension except under special extenuating circumstances when
the suspension period can be reduced or removed; always a disqualification from
the event and a fine; rankings of the particular event are frozen until completion
of process. A special procedure to permit provisional suspensions will be established.
Medication Class A: to be dealt with via fast track or hearing and
could be either a isqualification and fine or suspension. However, if the case
is referred to the Judicial Committee, then a suspension of up to 1 year could
also be imposed on top of the disqualification and fine. Medication
Class B: always via fast track unless a repeat offence. The sanction will
normally be a disqualification and/or a fine. Subject to extenuating circumstances
such a case could also be dealt with by a warning only. If a repeat offence within
two years, then it would be referred to the Judicial Committee who could impose
sanctions similar or the same as under Medication Class A offences. Repeat
Offence: Repeat offences within 5 years of the date of the offence for Doping
and Medication Class A, are always heard by the Judicial Committee which can impose
any sanction up to four years suspension for the PR. In case the first offence
is not known at the time of the second offence consideration must be given to
actual facts when deciding on the sanction. A sanction process, according
to which a full hearing must take place within 40 working days. is also established.
Media
and Communications:
The FEI communication process must be improved
significantly. A standard communications procedure will be put into place in order
provide consistent follow up both internally and externally. A professional
from the Communications Department will be selected as the only FEI spokesperson
on medication cases. This is of major importance especially during Games and Championships
or when high profile riders are involved. All other personnel, professionals or
elected officials, will be instructed to always refer to the spokesperson. A
detailed record of the status of each open case will be published on the FEI website
along with the expected times for the following steps in the procedure. Some
additional suggestions concerning the stewarding system, the role of judges and
their participation in control, standardisation of allowed in-competition treatment,
limitation of the number of Grand Prix starts, the regulation of prize money over
competitions, the role of modern course design and education, were also discussed.
Timetable:
Introduction of the recommendation will begin after the 2005
FEI General Assembly. The full system should be in place by 2006.
Muriel
Faienza Communication Manager Fédération Equestre Internationale Avenue
Mon-Repos 24 1005 Lausanne Switzerland t +41 21 310 47 47 f +41
21 310 47 60 www.horsesport.org #############################################################
|